Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04322539
Title A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Patients With Metastatic Colorectal Cancer (FRESCO-2)
Acronym FRESCO-2
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Hutchison Medipharma Limited
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | ITA | HUN | GBR | FRA | EST | ESP | DEU | CZE | BEL | AUT | AUS


No variant requirements are available.